Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway ; volume:47 ; number:6 ; year:2018 ; pages:2250-2260
Cellular physiology and biochemistry ; 47, Heft 6 (2018), 2250-2260
- Urheber
-
Hou, Teng
Zhou, Lijie
Wang, Longwang
Kazobinka, Gallina
Chen, Yumao
Zhang, Xiaoping
Chen, Zhaohui
- DOI
-
10.1159/000491536
- URN
-
urn:nbn:de:101:1-2018080200315045773465
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hou, Teng
- Zhou, Lijie
- Wang, Longwang
- Kazobinka, Gallina
- Chen, Yumao
- Zhang, Xiaoping
- Chen, Zhaohui
Ähnliche Objekte (12)
Roxarsone induces angiogenesis via PI3K/Akt signaling
Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT
Scutellaria barbata D.Don (SBD) extracts suppressed tumor growth, metastasis and angiogenesis in Prostate cancer via PI3K/Akt pathway
LINC01370 suppresses hepatocellular carcinoma proliferation and metastasis by regulating the PI3K/AKT pathway
Nucleolar protein 3 promotes proliferation of bladder cancer cells through the PI3K-Akt pathway
PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway
LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway
Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling
Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling
IL-22 activates the PI3K-AKT pathway to promote colorectal cancer cell proliferation and metastasis
TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
NOTCH3 promotes malignant progression of bladder cancer by directly regulating SPP1 and activating PI3K/AKT pathway
Roxarsone induces angiogenesis via PI3K/Akt signaling
Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT
Scutellaria barbata D.Don (SBD) extracts suppressed tumor growth, metastasis and angiogenesis in Prostate cancer via PI3K/Akt pathway
LINC01370 suppresses hepatocellular carcinoma proliferation and metastasis by regulating the PI3K/AKT pathway
Nucleolar protein 3 promotes proliferation of bladder cancer cells through the PI3K-Akt pathway
PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway
LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway
Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling
Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling
IL-22 activates the PI3K-AKT pathway to promote colorectal cancer cell proliferation and metastasis
TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
NOTCH3 promotes malignant progression of bladder cancer by directly regulating SPP1 and activating PI3K/AKT pathway
Roxarsone induces angiogenesis via PI3K/Akt signaling
Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT
Scutellaria barbata D.Don (SBD) extracts suppressed tumor growth, metastasis and angiogenesis in Prostate cancer via PI3K/Akt pathway
LINC01370 suppresses hepatocellular carcinoma proliferation and metastasis by regulating the PI3K/AKT pathway
Nucleolar protein 3 promotes proliferation of bladder cancer cells through the PI3K-Akt pathway
PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway
LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway
Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling
Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling
IL-22 activates the PI3K-AKT pathway to promote colorectal cancer cell proliferation and metastasis
TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer